📰 Nasdaq Bcab News
Page 2 - Nasdaq Bcab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Bcab. Real-time updates on events, politics, business and more.
May 28, 2023
Shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price […]
May 13, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,780,000 shares, a growth of 16.7% from the April 15th total of 3,240,000 shares. Based on an average daily trading volume, of 512,800 shares, the short-interest ratio is […]
May 5, 2023
Shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) have received a consensus rating of “Moderate Buy” from the six analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among brokers that […]
May 3, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) has been given an average rating of “Moderate Buy” by the six ratings firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target […]
May 2, 2023
Formidable Asset Management LLC lowered its position in shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) by 16.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,607 shares of the company’s stock after selling 6,813 shares during the […]
May 1, 2023
BioAtla (NASDAQ:BCAB – Get Rating) will be releasing its earnings data on Tuesday, May 2nd. BioAtla Stock Down 2.3 % Shares of BCAB opened at $3.37 on Monday. The company has a market capitalization of $160.45 million, a P/E ratio of -1.23 and a beta of 0.23. The firm has a 50 day moving average […]
April 1, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) insider Christian Vasquez acquired 20,000 shares of the firm’s stock in a transaction on Tuesday, March 28th. The shares were acquired at an average price of $2.40 per share, with a total value of $48,000.00. Following the completion of the purchase, the insider now owns 102,709 shares in the […]
March 30, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) insider Christian Vasquez bought 20,000 shares of BioAtla stock in a transaction that occurred on Tuesday, March 28th. The shares were acquired at an average price of $2.40 per share, with a total value of $48,000.00. Following the completion of the transaction, the insider now owns 102,709 shares of […]
March 30, 2023
BioAtla (NASDAQ:BCAB – Get Rating) had its price target reduced by analysts at BTIG Research to $13.00 in a research note issued to investors on Tuesday, The Fly reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price target indicates a potential upside of 417.93% from the stock’s previous close. A […]
March 27, 2023
BioAtla (NASDAQ:BCAB – Get Rating) had its price target cut by HC Wainwright from $20.00 to $17.00 in a research report sent to investors on Friday morning, The Fly reports. They currently have a buy rating on the stock. Separately, EF Hutton Acquisition Co. I assumed coverage on shares of BioAtla in a report on […]